Si-Bone chief op & financial officer sells $337,138 in stock By Investing.com

Anshul Maheshwari, Chief Operating and Financial Officer at SI-BONE, Inc. (), sold a total of 16,975 shares of the company’s common stock for a combined value of $337,138. The transactions occurred on August 19 and August 21, 2026.

On August 19, Mr. Maheshwari disposed of 5,747 shares at prices ranging from $19.50 to $19.67 per share. Two days later, on August 21, an additional 11,228 shares were sold, with prices for these transactions ranging from $20.00 to $20.05 per share. These sales were executed under a pre-arranged 10b5-1 trading plan, which was established on December 17, 2025. The timing coincides with strong stock performance, as shares have gained 29% over the past six months. However, InvestingPro analysis suggests the stock is currently overvalued relative to its Fair Value, placing it among companies on the Most Overvalued list.

Following these transactions, Mr. Maheshwari beneficially owns 234,920 shares of SI-BONE common stock. This total includes 167,604 shares issuable upon the settlement of restricted stock units. For deeper insights into SI-BONE’s financial health and valuation, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities.

In other recent news, SI-BONE reported its second-quarter 2026 earnings, surpassing Wall Street’s expectations. The company posted an adjusted loss of $0.09 per share, which was better than analysts’ projections of a $0.16 loss. Revenue increased by 15.2% to $56 million, slightly exceeding the forecasted $55.92 million. Despite these positive results, the stock experienced a decline in after-hours trading as investors considered the company’s future outlook and spending plans. Canaccord Genuity reiterated its Buy rating for SI-BONE, maintaining a price target of $27.00, citing strong U.S. surgeon engagement and procedural volume growth. The firm noted broad-based, double-digit growth across all call points. Additionally, SI-BONE raised its revenue and operating expense guidance based on these results. These developments reflect recent positive momentum for the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.